Besponsa Prices, Coupons, Copay Cards & Patient Assistance
Besponsa (inotuzumab ozogamicin) is a member of the miscellaneous antineoplastics drug class and is commonly used for Acute Lymphoblastic Leukemia.
Besponsa prices
Intravenous Powder For Injection
0.9 mg Besponsa intravenous powder for injection from $25,540.75 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $25,540.75 | $25,540.75 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Besponsa Coupons, Copay Cards and Rebates
Besponsa offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Besponsa Pfizer Oncology Together Co-Pay Savings Program
Eligible commercially insured patients may pay as little as $0 per month with savings of up to $25,000 per year; for additional information contact the program at 877-744-5675.
- Applies to:
- Besponsa
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Patient Assistance & Copay Programs for Besponsa
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Besponsa (inotuzumab ozogamicin) Vial; Single-Dose for Intravenous use
More information please phone: 800-675-8416 Visit website
Provider: Pfizer Patient Assistance Program
Eligibility requirements:- Uninsured or Underinsured
- Varies
- Not specified
- Must be residing in the US or US territory
- Pfizer also has programs that provide eligible patients with insurance, support assistance, and medicines at a savings. Contact Pfizer RxPathways for details (844-989-7284).
- Besponsa (inotuzumab ozogamicin) Vial; Single-Dose for Intravenous use
More information please phone: 866-706-2400 Visit website
Provider: Pfizer Oncology Together
Eligibility requirements:- Contact program for details.
- At or below 300% of FPL
- FDA-approved diagnosis
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Besponsa (inotuzumab ozogamicin) Vial; Single-Dose for Intravenous use
More information please phone: 877-744-5675 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Blinatumomab
Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell ...
Mercaptopurine
Mercaptopurine is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's disease ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
More about Besponsa (inotuzumab ozogamicin)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español